NCT02619838

Brief Summary

The objective of this study is to prospectively evaluate the mid-term results and intraoperative and postoperative complication rate in patients who underwent double or triple arthrodesis using CCS screws.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 7, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 2, 2015

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

March 24, 2025

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

8.3 years

First QC Date

October 15, 2015

Results QC Date

January 29, 2025

Last Update Submit

March 20, 2025

Conditions

Keywords

Double ArthrodesisTriple ArthrodesisSubtalar Arthrodesis

Outcome Measures

Primary Outcomes (8)

  • Number of Participants With Intraoperative Complications

    All intraoperative complications including injury of neurovascular structures and/or tendons will be prospectively documented. All intraoperative technical difficulties (for example, breakage of the screw) will be prospectively documented.

    At time of surgery

  • Number of Participants With Perioperative Complications

    All perioperative complications including wound healing problems and/or superficial/deep infection and/or deep vein thrombosis will be prospectively documented.

    Up to 2 years post-operative

  • Number of Participants With Delayed Osseous Union or Non-union

    Independent radiologist will measure fusion of standard of care radiographs and CT scan

    Up to 2 years post-operative

  • Number of Participants With Fixation of a Double or Triple Arthrodesis Neutral Hindfoot Alignment

    An independent radiologist will measure fusion of the double, triple, or subtalar fusion by reviewing the standard of care radiographs and CT scan and measuring the rate of fusion using the bridging of the trabecular bone.

    Up to 2 years post-operative

  • Pain Following Double or Triple Arthrodesis as Measured by a Visual Analogue Scale (VAS)

    The VAS ranges from 0 (no pain) to 10 (maximal pain).

    Baseline (pre-operative), 3 months, 6 months, 1 year, and 2 years post-operative

  • Functional Status Following Double or Triple Arthrodesis as Measured by the American Orthopaedic Foot and Ankle Society (AOFAS) Hindfoot Score

    The final score is the sum of the points across all 9 questions with a total score range of 0 to 28. A higher score indicates greater functionality.

    Baseline (pre-operative), 6 weeks, 3 months, 6 months, 1 year, and 2 years post-operative

  • Functional Status Following Double or Triple Arthrodesis as Measured by the Foot & Ankle Disability Index (FADI) Score

    The FADI has a total score range of 0 to 104, where a higher score indicates greater functionality.

    Baseline (pre-operative), 6 weeks, 3 months, 6 months, 1 year, and 2 years post-operative

  • Number of Participants With Secondary Surgical Procedures for Any Reason Including Hardware Removal

    All postoperative complications requiring any secondary surgical procedures including hardware removal will be prospectively documented.

    Up to 2 years post-operative

Study Arms (1)

Aptus CCS 5.0 or/and 7.0 screws

Procedure/Surgery: Subtalar, Double or Triple Arthrodesis of the talonavicular joint, the subtalar joint, and the calcaneal-cuboid joint of the foot with the Aptus CCS 5.0 or/and 7.0 screws

Device: Aptus CCS 5.0 or/and 7.0 screws

Interventions

Fusion of the talonavicular joint, the subtalar joint, and the calcaneal-cuboid joint with a Aptus CCS screws. The assignment of the device is at the discretion of the standard of care provider, not the study investigator.

Aptus CCS 5.0 or/and 7.0 screws

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon or his physician assistant based on clinical exam and radiographic findings. Patients of all racial, religious, and cultural backgrounds will be included in this study.

You may qualify if:

  • Rheumatoid or posttraumatic osteoarthritis of the hindfoot with involvement of subtalar, talonavicular, and calcaneocuboid joints (2;12).
  • Symptomatic rigid pes planovalgus et abductus with end-stage posterior tibial tendon dysfunction (e.g. grade IV) (4;13-15).
  • Neuromuscular disease mediated hindfoot deformities (16).
  • Tarsal coalitions (17).
  • Indication for calcaneocuboid arthrodesis: severe degenerative changes in the calcaneocuboid joint and/or severe abductus deformity of the forefoot.
  • Between the age 18-75

You may not qualify if:

  • Acute or chronic infection.
  • Poor vascular status of the lower leg (relative contraindication for double arthrodesis through a single medial approach).
  • Women that are pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27703, United States

Location

Results Point of Contact

Title
Mark Easley, M.D.
Organization
Duke University

Study Officials

  • Mark E. Easley, MD

    Duke Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2015

First Posted

December 2, 2015

Study Start

October 7, 2015

Primary Completion

January 29, 2024

Study Completion

January 29, 2024

Last Updated

March 24, 2025

Results First Posted

March 24, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be available. The results will be statistically analyzed as a whole.

Locations